Period | LI-NPPV | HI-NPPV | Difference between treatments (95% CI) | p Value | |
Paco2 (mm Hg) mean nighttime | Period 1 | 56.6±9.2 | 48.1±5.8 | −9.2 (−13.7 to −4.6) | 0.001 |
Period 2 | 57.2±7.7 | 47.3±9.3 | |||
HCO3− (mmol/l) mean nighttime | Period 1 | 31.3±2.2 | 28.9±1.9 | −1.9 (−3.5 to −0.3) | 0.022 |
Period 2 | 31.1±2.1 | 29.6±2.6 | |||
TLC (l) | Period 1 | 7.5±1.6 | 7.6±1.5 | 0.03 (−0.52 to 0.57) | 0.91 |
Period 2 | 7.4±0.8 | 7.3±1.5 | |||
FEV1 (l) | Period 1 | 0.64±0.11 | 0.97±0.46 | 0.05 (−0.01 to 0.11) | 0.086 |
Period 2 | 0.94±0.46 | 0.70±0.17 | |||
VC (l) | Period 1 | 1.82±0.23 | 2.22±0.59 | 0.08 (−0.2 to 0.36) | 0.55 |
Period 2 | 2.29±0.87 | 2.00±0.18 | |||
6MWD (m) | Period 1 | 271±56 | 302±163 | 14 (−42 to 70) | 0.58 |
Period 2 | 308±145 | 303±93 | |||
BDS after 6MWT | Period 1 | 6.5±2.8 | 3.4±3.6 | −2.4 (−4.3 to −0.4) | 0.025 |
Period 2 | 6.6±4.5 | 5.0±2.9 | |||
Paco2 (mm Hg) mean daytime | Period 1 | 51.8±8.6 | 50.1±3.0 | −2.9 (−7.1 to 1.4) | 0.17 |
Period 2 | 53.5±8.6 | 49.6±6.7 | |||
HCO3− (mmol/l) mean daytime | Period 1 | 30.1±2.7 | 29.4±1.3 | −1.0 (−2.5 to 0.5) | 0.18 |
Period 2 | 30.5±2.3 | 29.3±2.3 | |||
PImax (kPa) | Period 1 | 5.0±1.2 | 6.4±3.0 | 0.01 (−0.65 to 0.66) | 0.99 |
Period 2 | 5.3±1.9 | 4.6±1.7 | |||
SRI-SS | Period 1 | 60.3±12.9 | 65.3±21.2 | −0.14 (−4.9 to 4.6) | 0.95 |
Period 2 | 65.3±23.1 | 60.1±1\0.3 |
Data are presented as mean±SD.
6MWD, 6-minute walking distance; 6MWT, 6-minute walking test; BDS, Borg dyspnoea scale; FEV1, forced expiratory volume in 1 s; HI-NPPV, high-intensity non-invasive positive pressure ventilation; HCO3−, bicarbonate; LI-NPPV, low-intensity non-invasive positive pressure ventilation; Paco2, arterial carbon dioxide tension; PImax, maximal inspiratory mouth occlusion pressure; SRI-SS, Severe Respiratory Insufficiency Questionnaire Summary Score; TLC, total lung capacity; VC, vital capacity.